Picture of Sonoma Pharmaceuticals logo

SNOA — Sonoma Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Sonoma Pharmaceuticals Reports Qtrly Loss Per Share Of $0.77

July 10 (Reuters) - Sonoma Pharmaceuticals Inc  SNOA.O :
    * SONOMA PHARMACEUTICALS REPORTS FISCAL YEAR AND FOURTH
QUARTER
2020 FINANCIAL RESULTS
    * Q4 REVENUE ROSE 5 PERCENT TO $4.6 MILLION
    * QTRLY LOSS PER SHARE $0.77
    * AS OF MARCH 31, 2020, SONOMA HAD CASH AND CASH EQUIVALENTS
OF
$3.7 MILLION

Source text for Eikon:  ID:nBw7HWrJGa 
Further company coverage:  SNOA.O 

 (Reuters.Briefs@thomsonreuters.com)

Recent news on Sonoma Pharmaceuticals

See all news